In the present work, chrysin loaded bilosomes were formulated, characterized and evaluated to enhance the hepatoprotective activity of drug. Accordingly, chrysin loaded bilosomes were prepared by applying the thin film hydration method; also, fractional factorial design was used to optimize the production conditions of nanoformulations. The prepared formulations were subjected to different methods of characterization; then the hepatoprotective activity of the optimized one was evaluated in the CCl4 hepatointoxicated mice model. Optimized chrysin loaded bilosomes showed a spherical shape with a particle size of 232.97 ± 23 nm, the polydispersity index of 0.35 ± 0.01, the zeta potential of −44.5 ± 1.27 mv, the entrapment efficiency of 96.77 ± 0.18%, the drug loading % of 6.46 ± 0.01 and the release efficiency of 42.25 ± 1.04 during 48 h. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical-scavenging assay demonstrated the superiority of the anti-oxidant potential of chrysin loaded bilosomes, as compared to pure chrysin. This was in agreement with histopathological investigations, showing significant improvement in serum hepatic biomarkers of CCl4 intoxicated mice treated with chrysin loaded bilosomes, as compared with free chrysin. These results, thus, showed the potential use of bilosomes to enhance the hepatoprotective activity of chrysin via oral administration.
YenFLWuTHLinLT, et al.Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl 4-induced acute liver failure. Pharm Res2009; 26(4): 893–902.
2.
LeeCWYenFLHuangHW, et al.Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathways. J Agric Food Chem2012; 60(18): 4662–4671.
3.
HongMLiSWangN, et al.A biomedical investigation of the hepatoprotective effect of radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets. Int J Mol Sci2017; 18(3): 620.
4.
FarkhondehTSamarghandianSBafandehF. The cardiovascular protective effects of chrysin: a narrative review on experimental researches. Cardiovasc Hematol Agents Med Chem2019; 17(1): 17–27.
5.
PushpavalliGKalaiarasiPVeeramaniC, et al.Effect of chrysin on hepatoprotective and antioxidant status in D-galactosamine-induced hepatitis in rats. Eur J Pharmacol2010; 631(1-3): 36–41.
6.
BaltaCHermanHBolduraOM, et al.Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway. Chem Biol Interact2015; 240: 94–101.
7.
RashidSAliNNafeesS, et al.Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods2013; 23(5): 337–345.
8.
MohammadinejadSAkbarzadehARahmati-YamchiM, et al.Preparation and evaluation of chrysin encapsulated in PLGA-PEG nanoparticles in the T47-D breast cancer cell line. Asian Pac J Cancer Prev2015; 16(9): 3753–3758.
9.
ChakrabortySBasuSLahiriA, et al.Inclusion of chrysin in β-cyclodextrin nanocavity and its effect on antioxidant potential of chrysin: A spectroscopic and molecular modeling approach. J Mol Struct2010; 977(1-3): 180–188.
10.
DongDQuanEYuanX, et al.Sodium oleate-based nanoemulsion enhances oral absorption of chrysin through inhibition of UGT-mediated metabolism. Mol Pharm2017; 14(9): 2864–2874.
11.
BaidyaDKushwahaJMahadikK, et al.Chrysin-loaded folate conjugated PF127-F68 mixed micelles with enhanced oral bioavailability and anticancer activity against human breast cancer cells. Drug Dev Ind Pharm2019; 45(5): 852–860.
12.
SaifiZRizwanullahMMirSR, et al.Bilosomes nanocarriers for improved oral bioavailability of acyclovir: a complete characterization through in vitro, ex-vivo and in vivo assessment. J Drug Deliv Sci Technol2020; 57: 101634.
13.
SunJDengYWangS, et al.Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluation. Drug Deliv2010; 17(3): 164–170.
14.
NiuMLuYHovgaardL, et al.Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int IntJ Nanomedicine2011; 6: 1155.
15.
MohsenAMAsfourMHSalamaAA. Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes. Drug Dev Ind Pharm2017; 43(12): 2043–2054.
16.
GuanPLuYQiJ, et al.Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomed2011; 6: 965.
17.
ChenYLuYChenJ, et al.Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm2009; 376(1-2): 153–160.
18.
LiZZhangMLiuC, et al.Development of Liposome containing sodium deoxycholate to enhance oral bioavailability of itraconazole. Acian J Pharm2017; 12(2): 157–164.
19.
ZhangZLiHXuG, et al.Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids. Drug Deliv2018; 25(1): 1224–1233.
20.
BapatPGhadiRChaudhariD, et al.Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin. Int J Pharm2019; 560: 219–227.
21.
ArzaniGHaeriADaeihamedM, et al.Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. Int J Nanomed2015; 10: 4797.
22.
SatariNTaymouriSVarshosazJ, et al.Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy. Drug Dev Ind Pharm2020; 46(8): 1265–1277.
23.
El ZaafaranyGMAwadGAHolayelSM, et al.Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm2010; 397(1-2): 164–172.
24.
QushawyMNasrAAbd-AlhaseebM, et al.Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics2018; 10(1): 26.
25.
SalemHFNafadyMMAliAA, et al.Evaluation of Metformin Hydrochloride Tailoring Bilosomes as an Effective Transdermal Nanocarrier. Int J Nanomed2022; 17: 1185.
26.
NakhaeiPMargianaRBokovDO, et al. Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol. Front Bioeng Biotechnol2021; 9.
27.
Al-MahallawiAMAbdelbaryAAAburahmaMH. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm2015; 485(1-2): 329–340.
28.
VarshosazJTaymouriSJahanian‐NajafabadiA, et al.Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex‐vivo gut permeation study. IET nanobiotechnol2018; 12(6): 795–806.
29.
JavedIHussainSZUllahI, et al.Synthesis, characterization and evaluation of lecithin-based nanocarriers for the enhanced pharmacological and oral pharmacokinetic profile of amphotericin B. J Mater Chem B2015; 3(42): 8359–8365.
30.
GorjianHAmiriZRMilaniJM, et al.Preparation and characterization of the encapsulated myrtle extract nanoliposome and nanoniosome without using cholesterol and toxic organic solvents: A comparative study. Food Chem2021; 342: 128342.
31.
AhmedSKassemMASayedS. Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation. Int J Nanomed2020; 15: 9783.
32.
BnyanRKhanIEhtezaziT, et al.Formulation and optimisation of novel transfersomes for sustained release of local anaesthetic. J Pharm Pharmacol2019; 71(10): 1508–1519.
33.
ShahREldridgeDPalomboE, et al.Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Sci2014; 25(1).
34.
KovacevicASavicSVuletaG, et al.Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm2011; 406(1-2): 163–172.
35.
DaiYZhouRLiuL, et al.Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomed2013; 8: 1921.
36.
VonarbourgASaulnierPPassiraniC, et al.Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface. Electrophoresis2005; 26(11): 2066–2075.
37.
TaymouriSHajhashemiVTabbakhianM, et al.Preparation and Evaluation of Imatinib Loaded Transfersomal gel for the Treatment of Rheumatoid Arthritis. Iranian J Pharm Res2021; 20(4): 33–46.
38.
El MenshaweSFAboudHMElkomyMH, et al.A novel nanogel loaded with chitosan decorated bilosomes for transdermal delivery of terbutaline sulfate: artificial neural network optimization, in vitro characterization and in vivo evaluation. Drug Deliv Transl Res2020; 10(2): 471–485.
39.
El-NabarawiMNafadyMElmenshaweS, et al.Liver Targeting of Daclatasvir via Tailoring Sterically Stabilized Bilosomes: Fabrication, Comparative In Vitro/In Vivo Appraisal and Biodistribution Studies. Int J Nanomed2021; 16: 6413.
40.
AbbasHEl-FekyYAAl-SawahliMM, et al.Development and optimization of curcumin analog nano-bilosomes using 21.31 full factorial design for anti-tumor profiles improvement in human hepatocellular carcinoma: in-vitro evaluation, in-vivo safety assay. Drug Deliv2022; 29(1): 714–727.
41.
KulkarniADBelgamwarVS. Inclusion complex of chrysin with sulfobutyl ether-β-cyclodextrin (Captisol®): Preparation, characterization, molecular modelling and in vitro anticancer activity. J Mol Struct2017; 1128: 563–571.
42.
RadANShamsGSafdarianM, et al.Metformin loaded cholesterol-lysine conjugate nanoparticles: A novel approach for protecting HDFs against UVB-induced senescence. Int J Pharm2020; 586: 119603.
43.
WuTHYenFLLinLT, et al.Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int J Pharm2008; 346(1-2): 160–168.
44.
AhmedHASalamaZASalemSH, et al.Lyopene Nanoparticles Ameliorate The Antioxidants, Antimicrobial And Anticancer Potencies Of Tomato Pomace. Egypt J Chem2021; 64(7): 3739–3749.
45.
VieiraMVDernerRBLemos-SennaE. Preparation and characterization of Haematococcus pluvialis carotenoid-loaded PLGA nanocapsules in a gel system with antioxidant properties for topical application. J Drug Deliv Sci Technol2021; 61: 102099.
46.
PooniaNLatherVNarangJK, et al.Resveratrol-loaded folate targeted lipoprotein-mimetic nanoparticles with improved cytotoxicity, antioxidant activity and pharmacokinetic profile. Mater Sci Eng C2020; 114: 111016.
47.
EliyahuSAlmeidaAMacedoMH, et al.The effect of freeze-drying on mucoadhesion and transport of acrylated chitosan nanoparticles. Int J Pharm2020; 573: 118739.
48.
FontePSoaresSSousaF, et al.Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles. Biomacromolecules2014; 15(10): 3753–3765.
49.
ZakariaMYFayadEAlthobaitiF, et al.Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: Accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice. Drug Deliv2021; 28(1): 1150–1165.
50.
IsmailATeiamaMMagdyB, et al.Development of a Novel Bilosomal System for Improved Oral Bioavailability of Sertraline Hydrochloride: Formulation Design, In Vitro Characterization, and Ex Vivo and In Vivo Studies. AAPS Pharm Sci Tec2022; 23(6): 188.
51.
AbdouEMFayedMAHelalD, et al.Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles (LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl4 induced hepatotoxicity in rats. Sci Rep2019; 9(1): 1–4.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
